Chem_structure (Image 01)
Ipratropium Bromide Spray, Metered
Product Images NDC 68682-399
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 6 technical images submitted to the FDA as part of the official labeling for Ipratropium Bromide (NDC 68682-399). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Oceanside Pharmaceuticals, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Product Images & Figures Index
Carton (Image 02)
This text is a description of an Ipratropium Bromide Nasal Solution 0.06%, which is a medication used for nasal congestion relief in adults and children aged 5 years and older. The solution is available as a nasal spray containing 165 metered sprays. It is advised to administer two sprays per nostril, three or four times daily. The product must only be used intranasally and caution should be taken to avoid spraying in or around the eyes. The solution is manufactured by Bausch Health Companies Inc. in Canada and distributed by Oceanside Pharmaceuticals in the USA. It contains ingredients such as benzalkonium chloride, edetate disodium dihydrate, sodium chloride, and purified water.*
Figure 1 (Image 03)
Figure 2 (Image 04)
Figure 3 (Image 05)
Fgure 4 (Image 06)
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.
